Best Paper Award

Dear Colleagues,

We are pleased to announce the winners of the Vaccines 2021 Best Paper Award. All papers published in Vaccines from 1 January 2021 to 31 December 2021 were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, four winners were selected.

Two Reviews
(CHF 400 and a chance to publish a free paper in 2023 after peer review):
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
By Masaki Machida, Itaru Nakamura, Takako Kojima, Reiko Saito, Tomoki Nakaya, Tomoya Hanibuchi, Tomoko Takamiya, Yuko Odagiri, Noritoshi Fukushima, Hiroyuki Kikuchi, Shiho Amagasa, Hidehiro Watanabe and Shigeru Inoue
Vaccines 2021, 9(3), 210; https://doi.org/10.3390/vaccines9030210

Willingness to Receive COVID-19 Vaccination in Japan
By Takeshi Yoda and Hironobu Katsuyama
Vaccines 2021, 9(1), 48; https://doi.org/10.3390/vaccines9010048

Two Articles
(CHF 500 and a chance to publish a free paper in 2023 after peer review):
Nanomaterial Delivery Systems for mRNA Vaccines
By Michael D. Buschmann, Manuel J. Carrasco, Suman Alishetty, Mikell Paige, Mohamad Gabriel Alameh and Drew Weissman
Vaccines 2021, 9(1), 65; https://doi.org/10.3390/vaccines9010065

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
By Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, Dai Hai Nguyen, Ki Dong Park and Nghia P. Truong
Vaccines 2021, 9(4), 359; https://doi.org/10.3390/vaccines9040359

Please join us in congratulating the winners of the Vaccines 2021 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Vaccines.

Kind regards,
Vaccines Editorial Office

 
Vaccines 2021 Best Paper Award
 

Eligibility and Requirements

– All papers published in Vaccines will be eligible (Both regular and Special Issue submissions).
 
Past Winners
 
Year: 

Winner

17 pages, 1801 KiB  
Article
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
by Sasha E. Larsen, Jesse H. Erasmus, Valerie A. Reese, Tiffany Pecor, Jacob Archer, Amit Kandahar, Fan-Chi Hsu, Katrina Nicholes, Steven G. Reed, Susan L. Baldwin and Rhea N. Coler
Vaccines 2023, 11(1), 130; https://doi.org/10.3390/vaccines11010130 - 5 Jan 2023
13 pages, 1352 KiB  
Article
Factors Influencing Antibody Response to SARS-CoV-2 Vaccination
by Cathrin Kodde, Sascha Tafelski, Efthimia Balamitsa, Irit Nachtigall and Marzia Bonsignore
Vaccines 2023, 11(2), 451; https://doi.org/10.3390/vaccines11020451 - 15 Feb 2023
19 pages, 4521 KiB  
Systematic Review
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
by Hassen Mohammed, Dan Duy Pham-Tran, Zi Yi Michelle Yeoh, Bing Wang, Mark McMillan, Prabha H. Andraweera and Helen S. Marshall
Vaccines 2023, 11(2), 224; https://doi.org/10.3390/vaccines11020224 - 19 Jan 2023
21 pages, 1422 KiB  
Review
The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives
by Vincenzo Costanzo and Giovanni N. Roviello
Vaccines 2023, 11(2), 333; https://doi.org/10.3390/vaccines11020333 - 1 Feb 2023

Award Committee

Dr. Ralph Tripp Chairman
Univ Georgia
Prof. Christian Napoli
Department of Medical surgical sciences and translational medicine - Sapienza University of Rome
Dr. Zixin Wang
JC School of Public Health and Primary Care, the Chinese University of Hong Kong
Prof. Michael Bukrinsky
The George Washington University
Dr. Mariusz Skwarczynski
University of Queensland

Winner

26 pages, 748 KiB  
Review
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
by Alessio Facciolà, Giuseppa Visalli, Antonio Laganà and Angela Di Pietro
Vaccines 2022, 10(5), 819; https://doi.org/10.3390/vaccines10050819 - 22 May 2022
20 pages, 1903 KiB  
Review
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
by Anna Lucia Tornesello, Maria Tagliamonte, Franco M. Buonaguro, Maria Lina Tornesello and Luigi Buonaguro
Vaccines 2022, 10(2), 227; https://doi.org/10.3390/vaccines10020227 - 2 Feb 2022
12 pages, 4687 KiB  
Article
Evaluation of Transplacental Antibody Transfer in SARS-CoV-2-Immunized Pregnant Women
by Ching-Ju Shen, Yi-Chen Fu, Yen-Pin Lin, Ching-Fen Shen, Der-Ji Sun, Huan-Yun Chen and Chao-Min Cheng
Vaccines 2022, 10(1), 101; https://doi.org/10.3390/vaccines10010101 - 10 Jan 2022
13 pages, 3799 KiB  
Article
Therapeutic Effect of Subunit Vaccine AEC/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model
by Jinbiao Lu, Xiaonan Guo, Chunhua Wang, Weixin Du, Xiaobing Shen, Cheng Su, Yongge Wu and Miao Xu
Vaccines 2022, 10(5), 825; https://doi.org/10.3390/vaccines10050825 - 23 May 2022

Award Committee

Dr. Ralph Tripp Chairman
Univ Georgia
Prof. Michael Bukrinsky
The George Washington University
Prof. Christian Napoli
Department of Medical surgical sciences and translational medicine - Sapienza University of Rome
Prof. Sara Louise Cosby
Queen's University Belfast
Dr. Yashdeep Phanse
University of Wisconsin-Madison

Winner

11 pages, 252 KiB  
Article
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
by Masaki Machida, Itaru Nakamura, Takako Kojima, Reiko Saito, Tomoki Nakaya, Tomoya Hanibuchi, Tomoko Takamiya, Yuko Odagiri, Noritoshi Fukushima, Hiroyuki Kikuchi, Shiho Amagasa, Hidehiro Watanabe and Shigeru Inoue
Vaccines 2021, 9(3), 210; https://doi.org/10.3390/vaccines9030210 - 3 Mar 2021
8 pages, 780 KiB  
Article
Willingness to Receive COVID-19 Vaccination in Japan
by Takeshi Yoda and Hironobu Katsuyama
Vaccines 2021, 9(1), 48; https://doi.org/10.3390/vaccines9010048 - 14 Jan 2021
30 pages, 6597 KiB  
Review
Nanomaterial Delivery Systems for mRNA Vaccines
by Michael D. Buschmann, Manuel J. Carrasco, Suman Alishetty, Mikell Paige, Mohamad Gabriel Alameh and Drew Weissman
Vaccines 2021, 9(1), 65; https://doi.org/10.3390/vaccines9010065 - 19 Jan 2021
29 pages, 13825 KiB  
Review
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
by Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, Dai Hai Nguyen, Ki Dong Park and Nghia P. Truong
Vaccines 2021, 9(4), 359; https://doi.org/10.3390/vaccines9040359 - 8 Apr 2021
Back to TopTop